NOTV(Delisted)
Inotiv (NOTV) Stock Statistics, Valuation & Financial Metrics
Total Valuation
Inotiv market cap is -- and enterprise value is --.
Share Statistics
Inotiv has 34.89M shares outstanding, with a free float of 31.46M.
Valuation Ratios
Inotiv's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
Inotiv debt-to-equity ratio is 5.49 and debt-to-assets ratio is 0.89.
Liquidity
Inotiv's current ratio is 0.27, quick ratio is 0.21, and cash ratio is 0.03, showing its short-term liquidity position.
Return on Capital
Inotiv's ROE is -74.09%, ROA is -11.85%, and ROIC is -5.55%, showing its return on capital profile.
Profitability
Inotiv gross margin is 22.94%, operating margin is -9.48%, and net margin is -17.14%.
Operating Efficiency
Inotiv's asset turnover is 0.69, inventory turnover is 11.4, and receivables turnover is 7.67, indicating its operating efficiency.
Income Statement
Inotiv's revenue is 507.36M, gross profit is 116.41M, net income is -86.97M, and EBITDA is -28.82M.
Balance Sheet
Inotiv's total debt is 423.42M, net debt is 408.24M, total equity is 77.10M, and cash is 15.18M.
Cash Flow Statement
Inotiv's operating cash flow is 354.00K, free cash flow is -13.61M, and CapEx is -13.97M.
Dividends & Yields
Inotiv dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
Inotiv's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A leading contract research organization that provides contract-based bioanalytical, preclinical research services to pharmaceutical and drug development company
Per Share Metrics
Inotiv's EPS is -2.48, book value per share is 2.21, and free cash flow per share is -0.39.
